Login / Signup

A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).

Maryam ShamlooRebecca MollardHaizhou WangKulwant KingraNavdeep TangriDylan S MacKay
Published in: Trials (2022)
ClinicalTrials.gov NCT04961164 . Registered on 14 July 2021.
Keyphrases
  • phase iii
  • clinical trial
  • double blind
  • study protocol
  • phase ii
  • placebo controlled
  • open label